A clinical trial of dextromethorphan in amyotrophic lateral sclerosis

Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ole Gredal, Lene Werdelin, S. Bąk, Peter Brøgger Christensen, Gudrun Boysen, Michael Kristensen, Jesper Jespersen, Lisbeth Regeur, H H Hinge, Troels S. Jensen
Fformat: Artigo
Iaith:Saesneg
Cyhoeddwyd: 2009
Mynediad Ar-lein:https://doi.org/10.1111/j.1600-0404.1997.tb00231.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg